|
UBXN2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.152800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.289200E-01 |
| Normal-vs-Stage2 |
9.758600E-01 |
| Normal-vs-Stage3 |
6.523400E-01 |
| Normal-vs-Stage4 |
5.939800E-01 |
| Stage1-vs-Stage2 |
6.928400E-01 |
| Stage1-vs-Stage3 |
3.363600E-01 |
| Stage1-vs-Stage4 |
2.910000E-01 |
| Stage2-vs-Stage3 |
7.169000E-01 |
| Stage2-vs-Stage4 |
5.553400E-01 |
| Stage3-vs-Stage4 |
7.362000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.410400E-01 |
| Normal-vs-AfricanAmerican |
7.447000E-01 |
| Normal-vs-Asian |
6.892800E-01 |
| Caucasian-vs-AfricanAmerican |
4.352200E-01 |
| Caucasian-vs-Asian |
5.172800E-01 |
| AfricanAmerican-vs-Asian |
6.849200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.780000E-01 |
| Normal-vs-Female |
6.424400E-02 |
| Male-vs-Female |
2.720700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.943700E-02 |
| Normal-vs-Extreme_Weight |
3.033200E-01 |
| Normal-vs-Obese |
5.465200E-01 |
| Normal-vs-Extreme_Obese |
8.360600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.641400E-01 |
| Normal_Weight-vs-Obese |
3.016400E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.846200E-01 |
| Extreme_Weight-vs-Obese |
1.560960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.817200E-01 |
| Obese-vs-Extreme_Obese |
6.438200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.151900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.737400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.180600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.551210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.660200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.759370E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.197300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.583200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.016400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.811400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.327200E-01 |
| Normal-VS-Type2 PRCC |
3.364500E-03 |
| Normal-VS-KIRP CIMP |
2.040400E-03 |
| Normal-VS-Unclassified PRCC |
7.942800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.123100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.681099999997E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.840400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.36020000502435E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.002000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.246700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.754360E-02 |
| Normal-vs-N1 |
5.764100E-02 |
| Normal-vs-N2 |
5.836400E-01 |
| N0-vs-N1 |
5.118800E-03 |
| N0-vs-N2 |
1.395220E-01 |
| N1-vs-N2 |
6.972600E-01 |
|
|
